Development and Evaluation of O-CaP Core Nanoparticles for Efficient Non-Viral Gene Delivery
Trends in Pharmacy · 2025
DOI: 10.5152/trendspharm.2025.25006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Pharmacy, 2025. Verfasst von Hanife Sevgi Varlı.
Abstract (Originalsprache)
Background
Nanoparticles have gained significant attention in biomedical applications, particularly in gene delivery, due to their tunable physicochemical properties. A new core nanoparticle, O-CaP-2 (Octadecylamine- Calcium Phosphate core nanoparticle), was synthesized and evaluated for its physicochemical properties, cytocompatibility, and gene transfer efficiency.
Methods
In this study, 2 different nanoparticles were synthesized and characterized, and their transfection efficiency was evaluated. A core-shell structure was formed by coating calcium phosphate nanoparticles (CaP NPs) with octadecylamine nanoparticles (OD NPs) to enhance stability and cellular uptake. The synthesized nanoparticles were characterized in terms of size and surface charge usinga Zetasizer. Morphological properties were analyzed by scanning electron microscopy (SEM), while chemical interactions were investigated through Fourier transform infrared spectroscopy (FTIR). The cytotoxicity of the nanoparticles was assessedusing MTT (2,5-diphenyltetrazolium bromide [MTT, Thiazolyl blue]) assay over a 24-hour period. Finally, nanoparticles exhibiting optimal physicochemical properties and biocompatibility were selected for transfection studies. The transfection efficiency of these nanoparticles was evaluated to determine their potential for gene delivery applications.
Results
The O-CaP-2 nanoparticle, with a zeta potential of +24.3 mV, an average size of 184 nm, and a PDI (polydispersity index) of 0.2, was selected for further evaluation. Scanning electron microscopy imaging showed dense, spherical particles, while FTIR analysis confirmed the presence of octadecylamine and calcium phosphate. MTT assays indicated no cytotoxic effects across tested concentrations. Gene transfer studies achieved a transfection efficiency of 78% ± 5.18%, demonstrating O-CaP2’s potential as a safe and effective gene delivery vector.
Conclusion
The O-CaP-2 core nanoparticle, characterized by its favorable physicochemical properties, biocompatibility, and high transfection efficiency, demonstrates strong potential as a safe and effective non-viral gene delivery vector.Cite this article as: Varlı, H. S. Development and evaluation of O-CaP core nanoparticles for efficient non-viral gene delivery. Trends Pharm, 2025, 2, 0006. doi: 10.5152/TrendsPharm.2025.25006.
Zitieren
APA
Varlı, H. S. (2025). Development and Evaluation of O-CaP Core Nanoparticles for Efficient Non-Viral Gene Delivery. Trends in Pharmacy. https://doi.org/10.5152/trendspharm.2025.25006
Vancouver
Varlı HS. Development and Evaluation of O-CaP Core Nanoparticles for Efficient Non-Viral Gene Delivery. Trends in Pharmacy. 2025. doi:10.5152/trendspharm.2025.25006
BibTeX
@article{Varl2025,
author = {Varlı, Hanife Sevgi},
title = {Development and Evaluation of O-CaP Core Nanoparticles for Efficient Non-Viral Gene Delivery},
journal = {Trends in Pharmacy},
year = {2025},
doi = {10.5152/trendspharm.2025.25006}
}
EUVIMED